What is the share price of Par Drugs and Chemicals Ltd (PAR) today?
The share price of PAR as on 16th July 2025 is ₹95.51. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Par Drugs and Chemicals Ltd (PAR) share?
The past returns of Par Drugs and Chemicals Ltd (PAR) share are- Past 1 week: 1.57%
- Past 1 month: -1.97%
- Past 3 months: -3.01%
- Past 6 months: -49.17%
- Past 1 year: -60.20%
- Past 3 years: -46.87%
- Past 5 years: -33.28%
What are the peers or stocks similar to Par Drugs and Chemicals Ltd (PAR)?
The peers or stocks similar to Par Drugs and Chemicals Ltd (PAR) include:What is the market cap of Par Drugs and Chemicals Ltd (PAR) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Par Drugs and Chemicals Ltd (PAR) is ₹117.31 Cr as of 16th July 2025.What is the 52 week high and low of Par Drugs and Chemicals Ltd (PAR) share?
The 52-week high of Par Drugs and Chemicals Ltd (PAR) is ₹348.45 and the 52-week low is ₹81.01.What is the PE and PB ratio of Par Drugs and Chemicals Ltd (PAR) stock?
The P/E (price-to-earnings) ratio of Par Drugs and Chemicals Ltd (PAR) is 8.79. The P/B (price-to-book) ratio is 1.37.Which sector does Par Drugs and Chemicals Ltd (PAR) belong to?
Par Drugs and Chemicals Ltd (PAR) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Par Drugs and Chemicals Ltd (PAR) shares?
You can directly buy Par Drugs and Chemicals Ltd (PAR) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Par Drugs and Chemicals Ltd
PAR Share Price
PAR Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
AvgCan be considered moderately valued vs the market
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
PAR Performance & Key Metrics
PAR Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
8.77 | 1.37 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
37.80 | 6.51 | 0.80% |
PAR Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
PAR Company Profile
Par Drugs and Chemicals provides generic drugs. The Company is engaged in the development and manufacturing of Active Pharma Ingredients (APIs) for the domestic market, as well as for exports to international markets
PAR Forecast
PAR Forecasts
PAR
PAR
Income
Balance Sheet
Cash Flow
PAR Income Statement
PAR Income Statement
Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 48.81 | 42.42 | 46.42 | 55.94 | 62.93 | 75.25 | 95.99 | 95.88 | 103.12 | 103.12 | ||||||||||
Raw Materials | 19.59 | 17.94 | 19.22 | 22.19 | 22.09 | 29.61 | 41.03 | 33.32 | 81.47 | 81.47 | ||||||||||
Power & Fuel Cost | 8.45 | 6.94 | 8.90 | 10.70 | 9.82 | 13.49 | 17.83 | 16.40 | ||||||||||||
Employee Cost | 1.84 | 2.04 | 3.64 | 4.11 | 3.98 | 4.10 | 4.89 | 5.50 | ||||||||||||
Selling & Administrative Expenses | 3.30 | 2.81 | 1.97 | 4.58 | 5.62 | 8.22 | 9.60 | 10.16 | ||||||||||||
Operating & Other expenses | 7.13 | 4.67 | 4.39 | 4.81 | 3.23 | 3.40 | 4.20 | 7.44 | ||||||||||||
EBITDA | 8.50 | 8.02 | 8.30 | 9.55 | 18.19 | 16.43 | 18.44 | 23.06 | 21.65 | 21.65 | ||||||||||
Depreciation/Amortization | 2.82 | 3.14 | 3.04 | 2.76 | 2.82 | 3.28 | 3.23 | 3.44 | 3.65 | 3.64 | ||||||||||
PBIT | 5.68 | 4.88 | 5.26 | 6.79 | 15.37 | 13.15 | 15.21 | 19.62 | 18.00 | 18.01 | ||||||||||
Interest & Other Items | 2.50 | 2.33 | 1.96 | 0.79 | 0.64 | 0.45 | 0.13 | 0.11 | 0.08 | 0.08 | ||||||||||
PBT | 3.18 | 2.55 | 3.30 | 6.00 | 14.73 | 12.70 | 15.08 | 19.51 | 17.92 | 17.93 | ||||||||||
Taxes & Other Items | 1.34 | 1.06 | 0.78 | 1.23 | 3.11 | 3.49 | 3.75 | 5.02 | 4.57 | 4.56 | ||||||||||
Net Income | 1.84 | 1.49 | 2.52 | 4.77 | 11.62 | 9.21 | 11.33 | 14.49 | 13.35 | 13.37 | ||||||||||
EPS | 1.70 | 1.38 | 1.75 | 2.24 | 4.72 | 4.99 | 9.21 | 11.78 | 10.86 | 10.87 | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 1.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.56 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PAR Company Updates
Investor Presentation
Investor Presentation
PAR Stock Peers
PAR Past Performance & Peer Comparison
PAR Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Par Drugs and Chemicals Ltd | 8.79 | 1.37 | — |
Sun Pharmaceutical Industries Ltd | 37.93 | 5.72 | 0.93% |
Cipla Ltd | 22.84 | 3.85 | 1.07% |
Torrent Pharmaceuticals Ltd | 60.91 | 15.34 | 0.93% |
PAR Stock Price Comparison
Compare PAR with any stock or ETFPAR Holdings
PAR Shareholdings
PAR Promoter Holdings Trend
PAR Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
PAR Institutional Holdings Trend
PAR Institutional Holdings Trend
In last 3 months, retail holding in the company has decreased by 2.24%
In last 3 months, foreign institutional holding of the company has almost stayed constant
PAR Shareholding Pattern
PAR Shareholding Pattern
PAR Shareholding History
PAR Shareholding History
smallcases containing PAR stock
smallcases containing PAR stock
Looks like this stock is not in any smallcase yet.
PAR Events
PAR Events
PAR Dividend Trend
PAR has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
PAR Dividend Trend
PAR has not given any dividends in last 5 years
PAR Upcoming Dividends
PAR Upcoming Dividends
No upcoming dividends are available
PAR Past Dividends
PAR Past Dividends
Cash Dividend
Ex DateEx DateNov 22, 2021
Dividend/Share
₹1.25
Ex DateEx Date
Nov 22, 2021
Cash Dividend
Ex DateEx DateJul 10, 2020
Dividend/Share
₹1.25
Ex DateEx Date
Jul 10, 2020
Cash Dividend
Ex DateEx DateNov 22, 2019
Dividend/Share
₹1.25
Ex DateEx Date
Nov 22, 2019
PAR Stock News & Opinions
PAR Stock News & Opinions
Net profit of Par Drugs & Chemicals declined 55.65% to Rs 1.65 crore in the quarter ended March 2025 as against Rs 3.72 crore during the previous quarter ended March 2024. Sales declined 2.15% to Rs 22.33 crore in the quarter ended March 2025 as against Rs 22.82 crore during the previous quarter ended March 2024. For the full year,net profit declined 7.86% to Rs 13.36 crore in the year ended March 2025 as against Rs 14.50 crore during the previous year ended March 2024. Sales rose 5.57% to Rs 100.97 crore in the year ended March 2025 as against Rs 95.64 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales22.3322.82 -2 100.9795.64 6 OPM %10.8826.73 -19.3223.87 - PBDT3.206.00 -47 21.5822.96 -6 PBT2.285.11 -55 17.9319.52 -8 NP1.653.72 -56 13.3614.50 -8 Powered by Capital Market - Live
Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 8 May 2025.Powered by Capital Market - Live
Net profit of Par Drugs & Chemicals declined 83.04% to Rs 0.58 crore in the quarter ended December 2024 as against Rs 3.42 crore during the previous quarter ended December 2023. Sales declined 10.92% to Rs 21.38 crore in the quarter ended December 2024 as against Rs 24.00 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales21.3824.00 -11 OPM %6.6421.79 - PBDT1.685.44 -69 PBT0.774.57 -83 NP0.583.42 -83 Powered by Capital Market - Live
Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live
Par Drugs & Chemicals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 12 February 2025.Powered by Capital Market - Live
Par Drugs & Chemicals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 5 February 2025.Powered by Capital Market - Live
Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 11 January 2025.Powered by Capital Market - Live
Par Drugs & Chemicals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 31 December 2024 .Powered by Capital Market - Live
Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 2 December 2024Powered by Capital Market - Live
Net profit of Par Drugs & Chemicals rose 75.87% to Rs 8.60 crore in the quarter ended September 2024 as against Rs 4.89 crore during the previous quarter ended September 2023. Sales rose 33.87% to Rs 34.66 crore in the quarter ended September 2024 as against Rs 25.89 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales34.6625.89 34 OPM %32.9228.47 - PBDT12.407.39 68 PBT11.496.54 76 NP8.604.89 76 Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 13.01%, vs industry avg of 10.15%
Over the last 5 years, market share stayed at 0.02%
Over the last 5 years, net income has grown at a yearly rate of 22.85%, vs industry avg of 20.04%